Literature DB >> 22283670

How to evaluate microvascular organ damage in hypertension: assessment of endothelial function.

Agostino Virdis1, Stefano Taddei.   

Abstract

Patients with essential hypertension are characterized by endothelial dysfunction and impaired nitric oxide availability secondary to oxidative stress production. A dysfunctioning endothelium is an early marker of the development of atherosclerotic changes and can also contribute to cardiovascular events. The autocrine/paracrine activity of endothelial cells makes it very difficult to investigate endothelial function in clinical research. Vascular reactivity tests represent the most widely used methods of clinical assessment of endothelial function. The aim of these tests is to activate or block endothelial cell function while measuring consequent changes in vascular tone in selected vascular districts. Many studies have evaluated the endothelium in hypertensive patients, using different techniques. Several methodologies were developed to study microcirculation (resistance arteries and arterioles), both in coronary and peripheral vascular districts. In particular, peripheral microcirculation can be evaluated in functionally isolated vascular districts such as the peripheral muscle (usually forearm), the subcutaneous tissue, or the skin. This article focuses on the most relevant available techniques in the research on endothelial dysfunction in essential hypertension, in particular their advantages and major limitations. The coronary microcirculation can be evaluated by measuring coronary blood flow with Doppler flow wire and quantitative angiography during the intracoronary infusion of endothelial agonists. The isolated and perfused forearm technique is the most often used approach in the assessment of endothelial function in peripheral muscle microcirculation. The subcutaneous small resistance arteries can be studied using the Mulvany myograph device, an in vitro, ex vivo technique. Finally, the use of the laser digital Doppler technique provides a non-invasive approach to the evaluation of the skin microcirculation. Each technique employed to assess endothelial function has specific limitations that hinder its applicability in large-scale screening. In addition, studies assessing the degree of correlation among measures of endothelial function, as evaluated in different vascular beds, have demonstrated a poor relationship and, while statistically significant, the findings are of no clinical relevance. Therefore, no one technique can be considered a surrogate for another. At the present time, the optimal methodology for investigating the multifaceted aspects of endothelial dysfunction is still under debate. Only the growing concordant results from different reproducible and reliable methods exploring endothelial function with different stimuli will support and strengthen experimental findings, thus providing conclusive answers in this area of research.
© 2011 Adis Data Information BV. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22283670     DOI: 10.2165/11593630-000000000-00000

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  20 in total

Review 1.  Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.

Authors:  John Deanfield; Ann Donald; Claudio Ferri; Cristina Giannattasio; Julian Halcox; Sean Halligan; Amir Lerman; Giuseppe Mancia; James J Oliver; Achille C Pessina; Damiano Rizzoni; Gian Paolo Rossi; Antonio Salvetti; Ernesto L Schiffrin; Stefano Taddei; David J Webb
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

Review 2.  Endothelial function and dysfunction: testing and clinical relevance.

Authors:  John E Deanfield; Julian P Halcox; Ton J Rabelink
Journal:  Circulation       Date:  2007-03-13       Impact factor: 29.690

3.  Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients.

Authors:  U Solzbach; B Hornig; M Jeserich; H Just
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

4.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

5.  Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure.

Authors:  D Rizzoni; E Porteri; M Castellano; G Bettoni; M L Muiesan; G Tiberio; S M Giulini; G Rossi; G Bernini; E Agabiti-Rosei
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

6.  Lack of prognostic role of endothelial dysfunction in subcutaneous small resistance arteries of hypertensive patients.

Authors:  Damiano Rizzoni; Enzo Porteri; Carolina De Ciuceis; Gianluca E M Boari; Francesca Zani; Marco Miclini; Silvia Paiardi; Guido A M Tiberio; Stefano M Giulini; Maria Lorenza Muiesan; Maurizio Castellano; Enrico Agabiti Rosei
Journal:  J Hypertens       Date:  2006-05       Impact factor: 4.844

Review 7.  Endothelial function assessment in complicated hypertension.

Authors:  A Virdis; L Ghiadoni; D Versari; C Giannarelli; A Salvetti; S Taddei
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude.

Authors:  Jeffrey T Kuvin; Ayan R Patel; Kathleen A Sliney; Natesa G Pandian; Jacob Sheffy; Robert P Schnall; Richard H Karas; James E Udelson
Journal:  Am Heart J       Date:  2003-07       Impact factor: 4.749

9.  Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment.

Authors:  Dierk H Endemann; Qian Pu; Carolina De Ciuceis; Carmine Savoia; Agostino Virdis; Mario F Neves; Rhian M Touyz; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

10.  Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

Authors:  S Taddei; A Virdis; L Ghiadoni; A Magagna; A Salvetti
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690

View more
  2 in total

1.  Angiotensin-Converting Enzyme Inhibitor, Captopril, Improves Scar Healing in Hypertensive Rats.

Authors:  Eun Young Rha; Jae Won Kim; Jun Hyeok Kim; Gyeol Yoo
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

Review 2.  Anti-hypertensive Herbs and their Mechanisms of Action: Part I.

Authors:  Sara S Al Disi; M Akhtar Anwar; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-01-19       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.